Publications by authors named "Frigyes Waczek"

Claim this Profile
I
Identification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell lines.
Vassilis Mavromatidis, Zoltan Varga, Frigyes Waczek, Zoltán Őrfi, László Őrfi

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for MAPK modulators using an in-cell western assay.
Simon Schnaiter, Beatrix Fürst, Johannes Neu, Frigyes Wáczek, László Orfi

Methods Mol Biol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Novel method for the synthesis of carboxamides from low reactivity esters: synthesis of 2-acylamino-1-benzothiophene-3-carboxamides].
Péter Bánhegyi, Frigyes Wáczek, Zsolt Székelyhidi, Bálint Hegymegi-Barakonyi, György Kéri

Acta Pharm Hung· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
Rita Székely, Frigyes Wáczek, István Szabadkai, Gábor Németh, Bálint Hegymegi-Barakonyi

Immunol Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
György Kéri, Zsolt Székelyhidi, Péter Bánhegyi, Zoltán Varga, Bálint Hegymegi-Barakonyi

Assay Drug Dev Technol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
Zsolt Székelyhidi, János Pató, Frigyes Wáczek, Péter Bánhegyi, Bálint Hegymegi-Barakonyi

Bioorg Med Chem Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved, high yield synthesis of 3H-quinazolin-4-ones, the key intermediates of recently developed drugs.
László Orfi, Frigyes Wáczek, János Pató, István Varga, Bálint Hegymegi-Barakonyi

Curr Med Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis